Q4 FY26 saw 9.7% revenue growth and 25.9% higher adjusted EPS, with total enrollment up 8.4%. FY26 free cash flow rose 38.7% to $393 million, and $238 million was returned to shareholders. FY27 guidance anticipates continued revenue and EPS growth.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.